Results of ARIEL2: A Phase 2 trial to prospectively identify ovarian cancer patients likely to respond to rucaparib using tumor genetic analysis.
- Authors:
- IA McNeish, AM Oza, RL Coleman, CL Scott, GE Konecny, A Tinker, DM O'Malley, J Brenton, RS Kristeleit, K Bell-McGuinn, A Oaknin, A Leary, K Lin, M Raponi, H Giordano, S Goble, L Rolfe, R Yelensky, AR Allen, EM Swisher
- Journal:
- Journal of Clinical Oncology
- Citation info:
- 33(15_suppl):5508-5508
- Publication date:
- 20th May 2015
- Full text
- DOI